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Abstract
Background: Imbalances of gut microbiota composition are linked to a range of metabolic perturbations. In the
present study, we examined the gut microbiota of women with gestational diabetes mellitus (GDM) and
normoglycaemic pregnant women in late pregnancy and about 8 months postpartum.
Methods: Gut microbiota profiles of women with GDM (n = 50) and healthy (n = 157) pregnant women in the third
trimester and 8 months postpartum were assessed by 16S rRNA gene amplicon sequencing of the V1-V2 region.
Insulin and glucose homeostasis were evaluated by a 75 g 2-h oral glucose tolerance test during and after
pregnancy.
Results: Gut microbiota of women with GDM was aberrant at multiple levels, including phylum and genus levels,
compared with normoglycaemic pregnant women. Actinobacteria at phylum level and Collinsella, Rothia and
Desulfovibrio at genus level had a higher abundance in the GDM cohort. Difference in abundance of 17 species-
level operational taxonomic units (OTUs) during pregnancy was associated with GDM. After adjustment for pre-
pregnancy body mass index (BMI), 5 of the 17 OTUs showed differential abundance in the GDM cohort compared
with the normoglycaemic pregnant women with enrichment of species annotated to Faecalibacterium and
Anaerotruncus and depletion of species annotated to Clostridium (sensu stricto) and to Veillonella. OTUs assigned to
Akkermansia were associated with lower insulin sensitivity while Christensenella OTUs were associated with higher
fasting plasma glucose concentration. OTU richness and Shannon index decreased from late pregnancy to
postpartum regardless of metabolic status. About 8 months after delivery, the microbiota of women with previous
GDM was still characterised by an aberrant composition. Thirteen OTUs were differentially abundant in women with
previous GDM compared with women with previous normoglycaemic pregnancy.
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Conclusion: GDM diagnosed in the third trimester of pregnancy is associated with a disrupted gut microbiota
composition compared with normoglycaemic pregnant women, and 8 months after pregnancy, differences in the
gut microbiota signatures are still detectable. The gut microbiota composition of women with GDM, both during
and after pregnancy, resembles the aberrant microbiota composition reported in non-pregnant individuals with
type 2 diabetes and associated intermediary metabolic traits.
Keywords: Gut microbiota, Gestational diabetes, Pregnancy, Bacterial species, Body mass index, Glycaemic traits,
Gestational hyperglycaemia
Background
Pregnancy induces metabolic and immunological changes,
characterised by increased insulin resistance and immune
tolerance against the foetus and placenta [1, 2]. In predis-
posed women, these physiological changes may lead to the
development of gestational diabetes mellitus (GDM).
GDM is defined as abnormal glucose regulation with on-
set or first recognition during pregnancy and is one of the
most common complications during pregnancy with an
incidence of 2–6% of all pregnancies in Europe [3, 4].
GDM is a transient state, but even though glucose regula-
tion often normalises shortly after delivery, women with
GDM have a 40% increased risk of developing type 2 dia-
betes mellitus within a 10–15-year period [3, 5].
The influence of the gut microbial community on hu-
man health is becoming increasingly evident, and it has
been shown that patients with metabolic disorders such
as obesity and type 2 diabetes differ in faecal microbiota
composition from healthy individuals [6, 7]. Studies in-
vestigating the gut microbiota of healthy pregnant
women have documented profound alterations in com-
position from the first to the third trimester [8, 9].
Koren et al. found an increased abundance of Actinobac-
teria and Proteobacteria and a decreased abundance of
Faecalibacterium during the third trimester, resembling
the composition reported in non-pregnant adults with
metabolic syndrome. Interestingly, when germ-free mice
were inoculated with faeces from healthy women who
were pregnant in the third trimester, some metabolic
changes were demonstrated. The mice exhibited in-
creased weight gain, slightly lower insulin sensitivity and
a more pronounced inflammatory response when com-
pared with mice inoculated with faeces from healthy
women who were pregnant in the first trimester [8]; a
result partly similar to the effects observed in germ-free
mice when inoculated with microbiota from non-
pregnant obese human donors [10] and when adults
with metabolic syndrome is inoculated with microbiota
from lean non-pregnant donors [11]. In contrast to the
pronounced changes during pregnancy, no substantial
differences in the maternal microbial composition have
been reported when comparing late pregnancy to the
first months postpartum [8, 12].
Here, we hypothesise that GDM imposes changes in
the faecal microbiota (here termed gut microbiota) dur-
ing late pregnancy which are distinct from microbiota
changes of normal pregnant women and that some
microbiota aberrance remains postpartum in women
with previous GDM. Hence, we aimed to investigate the
differences in the gut microbiota and host metabolism
between normoglycaemic pregnant women and women
with newly diagnosed GDM in late pregnancy and on an
average 8 months postpartum where insulin sensitivity
and immune functions under normal circumstances
have returned to a habitual stage.
Methods
Study population and design
During January 2014 to February 2015, we phenotyped
at Herlev University Hospital in Denmark pregnant
women who were referred to a 2-h 75-g oral glucose tol-
erance test (OGTT) in their third trimester (27–33 ges-
tational weeks). Selected references to the hospitals were
due to the presence of risk factors for GDM (family his-
tory of type 2 diabetes mellitus; previous delivery of a
child weighing ≥ 4500 g at birth; glucosuria; pre-
pregnancy BMI ≥ 27 kg/m2; known polycystic ovarian
syndrome). In total, 790 women were invited to
participate in the project of whom 213 women were
included in the study as they fulfilled the inclusion
criteria of being singleton pregnant (verified by an
ultrasound scan), of Danish white origin and without
diagnosed pre-eclampsia at the time of inclusion. Mul-
tipara women with a previous normoglycaemic preg-
nancy were included. Women were excluded if they had
taken antibiotics within a period of 2 months before the
first visit. All included participants were re-invited for a
follow-up visit on an average of 8.8 months postpartum
(Additional file 1: Figure S1).
Anthropometrics and derived traits
Height was measured to the nearest 0.5 cm without
shoes using a wall-mounted stadiometer (first visit only).
Weight was measured to the nearest 0.1 kg on an elec-
tronic scale (TANITA BC-420MA, Tanita Corporation
of America, IL, USA) without shoes and dressed in light
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indoor clothing. Using a non-expandable measuring
tape, waist and hip circumferences were measured to the
nearest 1 cm in an erect position midway between the
iliac crest and the lower costal margin and at the level of
the pubic symphysis, respectively. Body composition was
assessed (postpartum only) using bioelectric impedance
analysis (TANITA BC-420MA, USA). Pre-pregnancy
weight was reported by the participants according to the
weight noted in their pregnancy health records. Twenty-
four women did not recall their weight before pregnancy
or did not bring their pregnancy health record at the
first visit. Body mass index (BMI) was calculated by div-
iding the weight in kilograms by the square of height in
meters. Normal weight was defined as BMI < 25 kg/m2,
overweight as BMI ≥ 25 kg/m2 and < 30 kg/m2 and
obesity as BMI ≥ 30 kg/m2 [13]. Weight gain during
pregnancy was calculated as the difference in measured
weight obtained at the first visit and self-reported pre-
pregnancy weight.
Blood pressure was recorded by an automatic sphyg-
momanometer (A&D Medical, Japan) as the mean of du-
plicate measurements in a sitting position after a 10-min
rest. Gestational hypertension was defined as develop-
ment of either a systolic blood pressure ≥ 140 mmHg, a
diastolic blood pressure ≥ 90 mmHg or both after
20 weeks of gestation [14].
Questionnaires, medical records and derived traits
Participants completed a questionnaire on health and
lifestyle, including information on smoking and alco-
hol consumption, stool consistency on the Bristol
stool scale and bowel habits and social and educa-
tional attainment. Physical activity was recorded using
a validated instrument by questionnaire [15]. At both
visits, dietary habits were recorded using a validated
food frequency questionnaire (FFQ) [16]. Intensity-
weighted activity levels were calculated as metabolic
equivalent of task (MET) hours per week [17]. Partici-
pants were asked to bring their medication and diet-
ary supplements at each visit, and exact daily dosages
were recorded. Information about gestational age at
previous birth, delivery method and antepartum,
intrapartum or postpartum antibiotic treatment was
obtained from the hospital birth records.
Biochemistry and derived traits
At both visits, the women were examined in the morn-
ing following a 10-h overnight fast.
Venous blood was collected in the fasting state for
hormonal and metabolic biomarkers. A standard 2-h
OGTT with 75 g of glucose dissolved in 200 ml of water
and sampling of venous blood at 0, 30, 60 and 120 min
was conducted.
Plasma glucose was analysed by the glucose oxidase
method using a colorimetric slide test on a Vitros 5600
system (Ortho Clinical Diagnostics, Raritan, NJ USA; co-
efficient of variation (CV) 6.1%) at the Department of
Clinical Biochemistry Herlev University Hospital during
pregnancy and at the Department of Clinical Biochemis-
try Rigshospitalet, Glostrup postpartum. Plasma insulin
was measured on a Roche cobas e411 system using an
enzyme-linked chemiluminescent immunoassay (Roche
Diagnostics GmbH, Mannheim, Germany; CV 2.8%).
High-sensitivity C-reactive protein (hsCRP) was mea-
sured on a Roche cobas c701 system using a particle-
enhanced turbidimetric immunoassay (Roche Diagnos-
tics GmbH, Mannheim, Germany) with an intra-assay
CV of 0.7–2.3%.
Homeostasis model assessment of insulin resistance
(HOMA-IR), insulinogenic index and disposition index
were calculated according to Matsuda et al. (mmatsuda.
diabetes-smc.jp/MIndex.html).
GDM was diagnosed according to the International Asso-
ciation of the Diabetes and Pregnancy Study Group
(IADPSG) criteria: one or more elevated values—fasting
plasma glucose ≥ 5.1 mmol/L and/or 1-h plasma glucose ≥
10.0 mmol/L and/or 2-h plasma glucose ≥ 8.5 mmol/L [18].
Descriptive analyses
Statistical analyses were performed using R Studio ver-
sion 1.0.136 (http://www.r-project.org/). Two-tailed Stu-
dent’s t test and the χ2 test were used to test the
differences in phenotypical characteristics. Variables
were log transformed to improve normality and
homoscedasticity where appropriate. A Wilcoxon
signed-rank test was applied for paired non-normally
distributed data. Linear mixed models were used to
compare dietary intake during pregnancy and
postpartum.
Microbiome analyses
DNA extraction, library preparation, sequencing and initial
preparation of data
Faecal samples were collected at home by the partici-
pants within 48 h of the OGTT, following a standardised
procedure including antiseptic handling, collection in
sterile tubes and immediate freezing at − 18 °C. The
samples were transferred to the laboratory on dry ice
within 48 h of collection and stored at − 80 °C until
DNA extraction. Two hundred nine women provided
faecal samples at baseline, 122 of whom also provided a
faecal sample postpartum.
We used the NucleoSpin Soil kit (Macherey-Nagel) to
extract the total faecal genomic DNA from 150 to
200 mg of faecal material [19]. The faecal material was
suspended in SL2 buffer containing SX enhancer, and
cell disruption was carried out by bead beating at 30 Hz
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for 5 min using a TissueLyser instrument (Qiagen). Suf-
ficient amounts of DNA could not be extracted from
four faecal samples due to too little material.
Variable regions V1-V2 of the 16S rRNA gene were
amplified using the 27F/338R primer pair [20]. The nor-
malisation of PCR product was performed using the
SequalPrep Normalization Plate Kit (Life Technologies).
Pooling and sequencing were done on the Illumina
MiSeq platform using a dual-indexing strategy [21] with
MiSeq Reagent Kits v2. Demultiplexing was based on
zero mismatches in the barcode sequence. The raw se-
quencing data was trimmed using sickle [22] in paired-
end mode, using default quality values and a minimum
read length of 100 bp after trimming. Forward and re-
verse read were merged using vsearch (v1.9, https://
github.com/torognes/vsearch), setting minimal and max-
imal overlap to 280 and 350 bp, respectively. Further
quality control included filtering based on a maximum
expected error of 1 (vsearch v1.9) and a read quality
below 30 in maximum 5% of the sequence, followed by
reference-based chimera detection using vsearch. Qual-
ity controlled reads were annotated using UTAX [23],
and sequences that could not be assigned to bacteria
and sequences assigned to chloroplasts were removed.
Picking of operational taxonomic units (OTUs) was per-
formed using vsearch based on the non-rarefied dataset
and an identity cut-off of 97%, excluding only singleton
sequences prior to clustering. OTU picking was followed
by a second step identifying chimeras, this time using a
de novo approach. The reads of each sample were
mapped to these OTU sequences, and 10,000 randomly
chosen sequences were used to construct the OTU
abundance table. Additionally, OTU sequences under-
went taxonomic annotation using the ribosomal data-
base project (RDP) classifier [24] and training set 16
provided on the RDP website (https://rdp.cme.msu.edu).
The cut-off for annotation was set to a classification
score of 0.8, assigning each OTU to the lowest taxo-
nomic level exceeding this threshold in the classification.
This classification was used to construct a taxonomic
abundance table based on the OTU abundance table,
collapsing OTUs assigned to the same taxon into one
taxonomic bin. The final dataset of the third trimester
pregnant women consisted of 209 samples (157 from
normoglycaemic women, 50 from women with GDM
and 2 from women with uncertain diabetes status due to
missing information about fasting plasma glucose level)
and 122 postpartum samples (79 and 43 from normogly-
caemic and diabetic women, respectively).
Data analyses
Alpha diversity metrics (richness and Shannon’s index)
were calculated using the phyloseq R package based on
rarefied OTU counts. Pielou’s evenness index was
calculated as Shannon’s index/ln (richness). The cross-
sectional difference in alpha diversity between groups
during pregnancy and postpartum was assessed using
Student’s t test. Change in alpha diversity from preg-
nancy to postpartum in women with available samples
from both time points was assessed using a mixed linear
regression with a random effect of the subject, for only
women with available samples at both time points. To
test for differential change in alpha diversity metrics
from pregnancy to postpartum in women with and with-
out GDM, an ANOVA model was fitted with a two-way
interaction between GDM status and time (factor with
four levels) as the independent variable and the contrast
Postpartum|Diabetic − Postpartum|Normoglycaemic −
Pregnant|Diabetic + Pregnant|Normoglycaemic was
tested using a post hoc t test. Models were fitted using
restricted maximum likelihood, and assumptions were
checked visually by inspection of residual plots (homo-
scedasticity) and normal probability plots (Gaussian dis-
tribution). Association between alpha diversity metrics
and glycaemic traits (fasting and 2 h plasma glucose
levels, insulin sensitivity and disposition index) was
tested using linear regression with and without adjust-
ment for pre-pregnancy BMI.
Analyses of community structure were performed
using the vegan R packages. The cross-sectional differ-
ence in community structure between women with and
without GDM and between women with GDM diag-
nosed by either fasting or stimulated hyperglycaemia or
a combination of the two was assessed by permutational
analysis of variance (PERMANOVA) of weighted Uni-
Frac distances, as implemented in the adonis function.
The association of glycaemic traits with community
structure was also assessed using PERMANOVA of
weighted UniFrac distances. Principal coordinate ordin-
ation was performed using the capscale function of the
vegan package, specifying an unconstrained model. Vec-
tors of glycaemic traits were fitted onto the ordination
using the envfit function. For longitudinal analyses of
community structure, PERMANOVA models were fitted
with permutations constrained within each individual.
Differential change in community structure from preg-
nancy to postpartum in women with and without GDM
was assessed by contrasting the levels of the interaction
between GDM status and time as described above.
To assess the cross-sectional differences at OTU level,
we performed differential abundance analyses on unrare-
fied, untransformed OTU tables using a negative bino-
mial Wald test as implemented in the DESeq2 R
package [25]. Only OTUs present in at least 10% of sam-
ples and with a mean proportional abundance of 0.01%
(561 of 5464 OTUs) were considered. OTUs exhibiting a
differential change from pregnancy to postpartum in
women with and without GDM were identified by a
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mixed linear model ANOVA, as described for alpha di-
versity metrics. For the longitudinal analyses, rarefied
(10,000 sequences per sample) OTU abundances were
added a pseudo count equal to the lowest non-zero
abundance of each OTU and log transformed. Only the
results significant at a 10% false discovery rate (ad
modum Benjamini-Hochberg) are reported.
At deeper taxonomic levels (biomarkers from phylum
to genus level), we performed linear discriminant ana-
lysis (LDA). Here, we applied LEfSe [26] with default pa-
rameters (alpha value for Wilcoxon tests was set at 0.05,
the logarithmic LDA score threshold set at 2.0) to iden-
tify taxonomic biomarkers that characterise the differ-
ences between women with and without GDM and
between pregnant women of different weight categories
(normal weight, overweight and obese).
To test the association of individual OTUs with weight
gain during pregnancy, a negative binomial Wald test as
implemented in the DESeq2 package was applied.
Weight gain was adjusted for small variation in gesta-
tional age by linear regression and discretiszed by a ter-
tile split. A negative binomial model was then specified
with weight gain tertiles as the explanatory variable and
pre-pregnancy BMI as a covariate (due to a strong in-
verse relationship between pre-pregnancy BMI and
weight gain). Finally, the log2 fold difference in abun-
dance between the upper and lower weight gain tertile
was tested using a post hoc Wald test to circumvent the
assumption of constant fold change for each unit change
of the independent variable. The association of individ-
ual OTUs with glycaemic traits was tested using the
same approach, contrasting the upper and lower tertiles
of each trait, with and without adjustment for BMI.
The associations between deeper order taxa (phylum
to genus level) and weight gain or glycaemic traits were
tested using Spearman correlation of rarefied (10,000
reads) read counts with and without prior adjustment of
the trait for pre-pregnancy BMI by linear regression. For
weight gain, additional adjustment for gestational age by
linear regression was performed prior to Spearman cor-
relation analysis.
Results
Description of the study cohort
GDM was diagnosed in 50 of 213 women due to fasting
(n = 25) or oral glucose-stimulated hyperglycaemia (n =
10) or a combination of the two (n = 15). As expected,
markers of glucose and insulin homeostasis were higher
in the GDM group compared with the group of normo-
glycaemic women (Table 1). Similarly, the Matsuda
index of insulin sensitivity was lower, and the HOMA
index of insulin resistance is higher in GDM (Table 1).
Women with GDM had indications of diminished beta
cell function as shown by lower insulinogenic index and
disposition index. The women diagnosed with GDM had
higher blood pressure (systolic 118 vs. 111 mmHg, P = 0.
0004; diastolic 71 vs. 67 mmHg, P = 0.001) and pre-
pregnancy BMI (29.3 vs. 27.1 kg/m2, P = 0.02) whereas
the two groups were comparable in age and height
(Table 1; Additional file 2: Table S1).
More than 80% of women in either group took multi-
vitamin supplements, and 2–3% took probiotic supple-
ments (Additional file 2: Table S1). The two groups were
comparable in terms of overall dietary intake based on
the distribution of macronutrients, Bristol stool scale
score and bowel movement frequency (Table 1;
Additional file 2: Table S1; Additional file 1: Figure S2).
The primary indication for referral to OGTT was
BMI ≥ 27 kg/m2 in both cohorts (50% in the GDM
cohort and 46% in the normoglycaemic cohort). Overall,
BMI ≥ 27 kg/m2 as the indication for OGTT accounted
for 46.9%, family history of type 2 diabetes accounted for
20.9% and a combination of risk factors for 18.5%.
Glucosuria, polycystic ovarian syndrome and previous
child with birth weight ≥ 4500 g were indications in 1.9,
7.6 and 4.3% of the cases, respectively (Additional file 2:
Table S2).
On an average of 8.8 months postpartum, 125 women
were re-examined, 43 women with GDM and 82 women
with normal glucose regulation during the preceding
pregnancy (Table 2; Additional file 2: Table S3). Plasma
glucose concentrations during OGTT were significantly
higher in women with previous GDM. The group of
women with previous GDM showed signs of insulin re-
sistance featured by increased plasma insulin levels dur-
ing the OGTT and decreased Matsuda index of insulin
sensitivity and a relatively reduced insulin secretion by a
decreased disposition index (Table 2). The two groups
were comparable in markers of lipid metabolism, inflam-
mation, dietary intake, breastfeeding, Bristol stool scale
and bowel movements (Table 2; Additional file 2: Table S3;
Additional file 1: Figure S3). About 33–35% of the women
took oral anticonceptives or had an intrauterine hormonal
contraception at the time of follow-up (Table 2). Overall,
dietary intake was significantly higher during pregnancy
compared with postpartum using mixed models analyses
(P < 0.05 in all tests) (Additional file 2: Table S4). No differ-
ences were shown in age, BMI or parity between the
women participating in the postpartum examinations com-
pared with the women who dropped out of the study.
Similar diversity and community structure in women with
gestational diabetes and normal glucose regulation
At a rarefied sequencing depth of 10,000 reads, we did
not find any difference in the number of observed
OTUs, Shannon’s diversity index or Pielou’s evenness
index between GDM and normoglycaemic women in the
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third trimester of pregnancy (Additional file 1: Figure S4).
When regressing alpha diversity measures against gly-
caemic traits, we found a nominally significant association
(P = 0.02) between the number of observed OTUs and
beta cell function represented by the disposition index,
but the association was insignificant at a 10% false discov-
ery rate (FDR) (Q = 0.2) (Additional file 1: Figure S5).
We also tested if GDM was associated with the overall
community structure and found no difference in un-
weighted UniFrac distances (R2 = 0.6%; P = 0.26) between
women with GDM and women with normal glucose
regulation (Fig. 1a). As fasting hyperglycaemia and
stimulated hyperglycaemia reflect two different
pathophysiological processes [27], we also tested
whether community structure differed in women with
GDM diagnosed by either fasting or stimulated
hyperglycaemia or a combination of the two, but we did
not see any such association (Fig. 1b). However, when
testing the association between fasting and stimulated
glucose concentrations during pregnancy, we found a
weak, nominally significant association between fasting
plasma glucose levels and unweighted UniFrac distances
(R2 = 1.0%; P = 0.037; Fig. 1c), but no association with
stimulated 2-h plasma glucose level, insulin sensitivity or
disposition index.
Taxonomic biomarkers of gestational diabetes
Compositionally, the gut microbiota of the total group
of pregnant women was dominated by members of the
two major bacterial phyla Firmicutes and Bacteroidetes,
which on average accounted for ~ 90% of all reads
(Additional file 1: Figures S6 and S7). At the genus level,
the composition followed a typical westernised pattern
Table 1 Clinical variables of GDM and normoglycaemic women in the third trimester pregnancy
GDM (n = 50) Normoglycaemic (n = 161) P
Descriptive measurements
Age (years) 34.4 (4.4) 33.3 (4.6) 0.1
Gestational week at examination 28.7 (1.4) 28.4 (1.1) 0.1
Systolic BP (mmHg) 118 (11.2) 111 (10.6) 0.001
Diastolic BP (mmHg) 71 (8.1) 67 (8.5) 0.001
Height (cm) 168.6 (6.6) 169.7 (5.6) 0.2
Weight (kg) 91.8 (14.1) 87.3 (14.6) 0.06
Pre-pregnancy weight (kg) (n = 190) 83.5 (16.0) (n = 43) 78.48 (15.2) (n = 145) 0.06
Pre-pregnancy BMI kg/m2(n = 189) 29.3 (5.6) (n = 43) 27.1 (4.8) (n = 144) 0.02
Weight gain (kg) 7.4 (4.7) 8.8 (7.5) 0.3
Normal and excessive weight gain (n) 3 excessive (13.0%)
20 normal (87.0%)
17 excessive (16.2%)
88 normal (83.8%)
1
Biochemistry
Glucose at time 0 min (mmol/L) 5.2 (0.4) 4.6 (0.2) 5.8 × 10−31
Glucose at time 30 min (mmol/L) 8.1 (1.0) 6.9 (0.9) 2.7 × 10−12
Glucose at time 60 min (mmol/L) 8.9 (1.3) 7.1 (1.2) 1.9 × 10−15
Glucose at time 120 min (mmol/L) 7.9 (1.4) 6.2 (1.0) 5.0 × 10−17
Insulin at time 0 min (pmol/L) 112.1 (40.6) 82.7 (39.6) 3.3 × 10−5
Insulin at time 30 min (pmol/L) 519.7 (1.6) 504.3 (1.7) 0.7
Insulin at time 60 min (pmol/L) 698.0 (1.8) 583.9 (1.7) 0.058
Insulin at time 120 min (pmol/L) 750.5 (1.8) 482.2 (1.7) 6.3 × 10−6
HbA1c (mmol/mol) 34.0 (3.1) 33.0 (2.8) 0.02
HOMA-IR 2.1 (0.8) 1.5 (0.7) 1.3 × 10−6
Matsuda index 3.5 (1.5) 5.3 (1.6) 3.0 × 10−8
Disposition index 4.1 (1.6) 7.8 (1.6) 9.2 × 10−12
Insulinogenic index 1.2 (1.6) 1.5 (1.6) 0.004
hsCRP (mg/L) 4.4 (1.9) 3.8 (2.2) 0.2
Data presented as mean (SD). For continuous variables, P was calculated by two-tailed t test, and for categorical variables, P was calculated by chi-square test or
Fisher’s exact test
BMI body mass index, BP blood pressure, GA gestational age, HbA1c glycated haemoglobin, HOMA-IR homeostatic model of insulin resistance, hsCRP high sensitive
C-reactive protein
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with Bacteroides as the predominant genus in women
with gestational diabetes and normal glucose regulation
alike (> 10% of all reads) and Faecalibacterium, Prevo-
tella and unclassified Lachnospiraceae each accounting
for > 5% of all reads on average, albeit as expected with
substantial inter-individual variation (Additional file 1:
Figure S8).
Using linear discriminant analyses, we identified
phylum Actinobacteria and several subordinate taxa
as taxonomic biomarkers of GDM (Fig. 2a, b): genus
Collinsella and the parent family Coriobacteriaceae
and parent order Coriobacteriales; genus Rothia and
the parent family Micrococcaceae and parent order
Actinomycetales; and genus Actinomyces, also of order
Actinomycetales. Within the phylum Proteobacteria,
the genus Desulfovibrio was a biomarker of GDM.
Within Firmicutes, the genus Leuconostoc and parent
family Leuconostocaceae, genus Granulicatella and
genus Mogibacterium were biomarkers of GDM,
whereas the genera Marvinbryantia, Acetivibrio and
Anaerosporobacter were markers of normal glucose
regulation.
Using a negative binomial Wald test, we identified 17
species-level OTUs, predominantly within Firmicutes
(15 out of 17), which in the third trimester were differ-
entially abundant in women with GDM and women with
normal glucose regulation at a false discovery rate of
10%. Three OTUs assigned to Blautia (OTU_2693),
Ruminococcus (of family Lachnospiraceae; OTU_1215)
and Faecalibacterium (OTU_ 2674) were enriched in
women with gestational diabetes. In contrast, 14 OTUs
assigned to Acetivibrio (OTU_775), Intestinimonas
(OTU_286), Erysipelotrichaceae incertae sedis (OTU_
163), Isobaculum (OTU_595), Butyricicoccus (OTU_458)
, Clostridium IV (Ruminococcaceae; OTU_68), Clostrid-
ium XVIII (Erysipelotrichaceae; OTU_95), Oscillibacter
(OTU_149), Ruminococcus (Ruminococcaceae; OTU_
130), Bacteroides (OTU_4999), Veillonella (OTU_15)
and Suterella (OTU_121) and two assigned to Faecalibac-
terium (OTU_3232 and OTU_4746) were depleted in
women with GDM (Fig. 3a; Additional file 2: Table S5).
Association of microbial composition with glycaemic
traits and inflammatory marker
We used Spearman correlation to identify deeper level
taxa associated with glycaemic traits in pregnant women
regardless of diabetes status and found that genus Col-
linsella and all parent taxa within Actinobacteria were
positively correlated with fasting plasma glucose, but the
association was abolished when adjusting for pre-
pregnancy BMI (Fig. 4). BMI adjustment did, however,
reveal a negative association between Butyricicoccus and
Table 2 Clinical variables of GDM and normoglycaemic women at postpartum approximately 8 months after delivery
Previous GDM (n = 43) Previous normoglycaemic (n = 82) P
Descriptive measurements
Systolic BP (mmHg) 120 (11.2) 116 (8.7) 0.04
Diastolic BP (mmHg) 79 (8.2) 75 (8.0) 0.03
BMI (kg/m2) 30.0 (5.9) 29.2 (5.0) 0.4
Weight (kg) 85.3 (16.9) 84.6 (15.4) 0.8
Fat (%) 41.3 (6.6) 40.2 (6.4) 0.3
Biochemistry
Glucose at time 0 min (mmol/L) 5.4 (0.4) (n = 41) 5.1 (0.3) (n = 73) 3.7 × 10−5
Glucose at time 30 min (mmol/L) 7.7 (1.1) 7.0 (1.0) 0.001
Glucose at time 60 min (mmol/L) 7.7 (1.9) 6.6 (1.4) 0.004
Glucose at time 120 min (mmol/L) 6.5 (1.2) 6.0 (1.0) 0.025
Insulin at time 0 min (pmol/L) 63.7 (1.7) 54.1 (2.1) 0.1
Insulin at time 30 min (pmol/L) 376.8 (1.7) 307.1 (1.8) 0.05
Insulin at time 60 min (pmol/L) 433.9 (1.9) 303.8 (1.9) 0.004
Insulin at time 120 min (pmol/L) 298.0 (1.8) 235.9 (2.0) 0.05
HOMA2-IR 1.4 (0.7) 1.3 (0.9) 0.4
Matsuda Index 5.8 (1.6) 7.6 (1.8) 0.01
Disposition Index 6.6 (2.1) 8.9 (2.0) 0.05
Insulinogenic index 1.15 (1.9) 1.17 (1.9) 0.9
Data presented as mean (SD) and range. For continuous variables, P was calculated by two-tailed t test, and for categorical variables, P was calculated by chi-square test
or Fisher’s exact test. Two women from the GDM group only had fasting blood samples taken at the follow-up visit. Eleven samples of fasting glucose were coagulated
and rejected by the department investigating glucose
BMI body mass index, BP blood pressure, GA gestational age, HOMA-IR homeostatic model of insulin resistance
Crusell et al. Microbiome  (2018) 6:89 Page 7 of 19
insulin sensitivity (r = − 0.12; Q = 0.08) and positive cor-
relations between stimulated 2-h plasma glucose level
and Prevotella (r = 0.25; Q = 0.03) and Faecalitalea (r
= 0.26; Q = 0.03). Also, associated with lower insulin
sensitivity after adjustment for BMI were order
Verrucomicrobiales and all parent taxa within
Fig. 1 Community structure in women with and without gestational diabetes. For all analyses, samples were rarefied to an equal sequencing
depth of 10,000 reads prior to principal coordinate (PCo) ordination based on weighted UniFrac distances. a Samples from pregnant women in
the third trimester with (n = 50) or without (n = 157) gestational diabetes. Points are individual samples, and diamonds represent the average
ordination scores and ellipses the 95% confidence intervals of a multivariate normal distribution of either group. R2 and P are from the permutational
multivariate analysis of variance (PERMANOVA) as implemented in the adonis function of the vegan R package. b Community structure in pregnant
women with gestational diabetes diagnosed by fasting hyperglycaemia (n = 25) or stimulated hyperglycaemia (2 h after an oral glucose challenge; n =
8), respectively, or by both (n = 15). Configuration is similar to panel a. c The association between glycaemic traits and community structure during
pregnancy regardless of GDM status as determined by PERMANOVA. Vectors representing direction and magnitude of each trait were fitted onto the
first and second PCo axes using the envfit function of the vegan R package. d Change in community structure from pregnancy to postpartum. Only
samples from women examined at both time points are included (n = 43 and n = 79 for women with and without GDM, respectively). R2 and P are
from PERMANOVA testing for a difference in community structure between samples collected during the third trimester and those collected
postpartum and for a differential change in community structure in women with GDM compared to women without GDM
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Verrucomicrobia. Akkermansia, the dominant genus
within Verrucomicrobiales, was nominally associated
with lower insulin sensitivity (r = − 0.22; P = 0.003) ad-
justed for BMI, but the association was not significant
at a 10% FDR (Q = 0.154).
In order to identify species-level OTUs associated with
glycaemic traits, we divided the samples into tertiles ac-
cording to the fasting plasma glucose level, stimulated
20-h plasma glucose level, insulin sensitivity index
(Matsuda) and disposition index (as a measure of insulin
sensitivity adjusted beta cell function) and contrasted
the upper and lower tertiles of each trait. We identified 50
significant associations (FDR 10%) between 42 unique
OTUs and the 4 glycaemic traits (Additional file 2: Table
S6; Additional file 1: Figure S9). Nineteen were associated
with stimulated 2-h plasma glucose level, 13 with insulin
sensitivity and disposition index, respectively, and 5 were
associated with a fasting plasma glucose level. Four OTUs
Fig. 2 Taxonomic biomarkers of gestational diabetes during pregnancy and postpartum. Cladogram (a, c) and scores (b, d) of taxonomic
biomarkers down to genus level identified by linear discriminant analysis (LDA) using LEfSe during pregnancy (a, b) and postpartum (c,
d). Colour indicates the group in which a differentially abundant taxon is enriched (red: GDM and previous GDM; blue: normoglycaemic
and previous normoglycaemic pregnancy)
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assigned to the genus Blautia (OTU_2383, OTU_3654,
OTU_140, OTU_2684) were associated with higher stim-
ulated 2-h plasma glucose level. One of the four Blautia
phylotypes (OTU_2383) was also associated with a higher
fasting plasma glucose level and lower insulin sensitivity
and disposition index, a pattern that was shared by the
other three Blautia OTUs (OTU_3654, OTU_140, OTU_
2684). One Blautia phylotype (OTU_486) exhibited the
exact opposite pattern, being associated with lower fasting
and stimulated 2-h plasma glucose levels and higher insu-
lin sensitivity. Three Escherichia/Shigella phylotypes
(OTU_680, OTU_361, OTU_3) were associated with
higher disposition index and exhibited an identical pattern
for the remaining traits (lower insulin sensitivity and
higher fasting and stimulated 2-h plasma glucose levels).
Due to the strong association between pre-pregnancy
obesity and microbial composition, we repeated the tests
adjusting for pre-pregnancy BMI. Only ten associations
between nine unique OTUs and the four glycaemic traits
remained significant after the adjustment (Additional file 2:
Table S6; Additional file 1: Figure S10). Notably, none of
the 19 OTUs associated with stimulated 2-h plasma glu-
cose level withstood the adjustment. Similarly, for insulin
sensitivity, only 3 out of 13 associations remained; all three
OTUs were associated with higher insulin sensitivity.
Adjusting for pre-pregnancy BMI did, however, reveal
Fig. 3 Operational taxonomic units differentially abundant during pregnancy and postpartum in women with GDM and normal glucose regulation.
Volcano plot of estimated log2 fold difference in operational taxonomic unit (OTU) abundance between women with (n = 50) and without (n = 157)
gestational diabetes during pregnancy (a) and postpartum (b) between women with (n = 43) and without (n = 79) previous gestational diabetes and
corresponding Benjamini-Hochberg adjusted P values (Q) from negative binomial Wald tests as implemented in the DESeq2 R package. Prevalence
indicates the percentage of participants in which a given OTU is present. Abundance indicates mean relative abundance (ppm) of a given
OTU during the third trimester and postpartum. Names of OTUs differentially abundant at a 10% false discovery rate are given at the
genus level
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Fig. 4 Bacterial genera associated with glycaemic traits during pregnancy regardless of GDM status. Heatmap of correlations (Spearman’s rho)
between bacterial genera and fasting plasma glucose, stimulated 2-h glucose, insulin sensitivity and disposition index, with and without adjustment
for body mass index. Only taxa nominally associated with either of the four traits are depicted. Taxa are ordered taxonomically. Results for all taxa are
presented in Additional file 2: Table S5. *P≤ 0.05, **P≤ 0.01, ***P≤ 0.001
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several associations not previously detected, most of
which involving Clostridiales species (12 of 17) and fasting
plasma glucose level (10 of 17), including one Christense-
nella OTU (OTU_63) which was associated with higher
fasting plasma glucose concentration. The strongest asso-
ciation, however, was between a Clostridium IV OTU
(OTU_68) and lower 2-h plasma glucose level (log2 fold
difference = − 25.45; Q = 1.1 × 10−26).
As the late pregnancy is defined as a pro-inflammatory
state [1, 28], we wanted to investigate if differential taxa
correlated with plasma levels of high-sensitive C-reactive
protein (hsCRP) in pregnancy and postpartum, regard-
less of metabolic status. We used Spearman correlation
to identify associations with higher order taxa; however,
none of the findings withstood the adjustment for mul-
tiple testing (Additional file 2: Table S7). As with the
maternal glycaemic traits, we divided the levels of
plasma hsCRP into tertiles and contrasted the upper ter-
tile to the lower in order to identify species-level OTUs
that associated with plasma hsCRP during pregnancy
and postpartum (Additional file 2: Table S8). Interest-
ingly, Bacteroides (OTU_4999) both during pregnancy
and postpartum is associated with higher levels of
plasma hsCRP, whereas Alistipes (OTU_98) and Anaero-
vorax (OTU_538) are associated with lower levels of
plasma hsCRP at both time points.
Partial confounding effect of BMI
Overweight and obesity are known risk factors for GDM
[29], and increased BMI has been associated with gut
microbiota disruption in both pregnant [30, 31] and
non-pregnant women [32]. In light of this and the over-
representation of obesity among women with gestational
diabetes (46.5 vs. 27.0% of women with normal glucose
regulation (Additional file 1: Figure S11) in our cohort,
we looked for microbial biomarkers of excess body
weight in order to assess the potential confounding ef-
fect of BMI.
Comparing pregnant women with pre-pregnancy BMI
within the overweight range (25–29.9 kg/m2) to women
with normal (< 25 kg/m2) pre-pregnancy BMI, we identi-
fied Parabacteroides and Porphyromonas as biomarkers
of overweight (Additional file 1: Figure S12), whereas
Akkermansia and all parent taxa within Verrucomicrobia
were markers of normal weight, as were the genera
Eggerthella and Sporobacter, as well as genera Ethanoli-
genens and Clostridium XVIII (Erysipelotrichaceae).
Comparing pregnant women with pre-pregnancy obes-
ity (BMI ≥ 30 kg/m2) to women with normal (< 25 kg/
m2) pre-pregnancy BMI identified the genera Porphyro-
monas, Acidaminococcus and Ruminococcus (Lachnos-
piraceae) as markers of obesity and the genera
Ethanoligenens, Sporobacter, and Eggerthella, as well as
an unclassified Erysipelotrichaceae genus, as markers of
normal weight. Notably, there was no overlap between
the taxonomic biomarkers of GDM and the markers of
overweight and obesity.
Disregarding the weight categories by correlating pre-
pregnancy BMI with taxa abundances confirmed the re-
sults, showing that genus Acetivibrio (r = − 0.16; P = 0.
03) and genus Leuconostoc (r = 0.15; P = 0.04) were the
only GDM discriminant taxa nominally associated with
pre-pregnancy BMI (Additional file 2: Table S9).
At OTU level, we primarily found that OTUs are dif-
ferentially abundant comparing women with pre-
pregnancy normal weight to women that were obese
pre-pregnancy. Ten OTUs were enriched in the obese
women, and 12 OTUs were depleted compared to pre-
pregnancy lean women. Only three OTUs showed differ-
ential abundance between pre-pregnancy lean women
and pre-pregnancy overweight women (Additional file 2:
Table S10; Additional file 1: Figure S13).
At OTU level, adjusting for pre-pregnancy BMI re-
duced the number of differentially abundant OTUs to
five, two of which were enriched in women with GDM
and three of which were depleted (Additional file 2:
Table S11; Additional file 1: Figure S14). Of those
enriched in women with GDM in the full cohort, only
one assigned to Faecalibacterium (OTU_2674) remained
after the adjustment, whereas two depleted in women
with GDM, both assigned to Veillonella (OTU_1626 and
OTU_15), remained. One OTU assigned to Anaerotrun-
cus (OTU_674) was enriched in women with GDM fol-
lowing adjustment for pre-pregnancy BMI, and another
OTU assigned to Clostridium (sensu stricto) (OTU_
1712) was depleted, neither of which were among the
OTUs differentially abundant in the full cohort. They
were, however, differentially abundant in the subcohort
of women with known pre-pregnancy BMI (43 with
GDM and 143 with normal glucose regulation) in which
the adjusted analyses were conducted (Additional file 2:
Table S11; Additional file 1: Figure S14A).
Adjusting for BMI did not affect the comparison of
alpha diversity measures between women with GDM
and with normal glucose regulation (P = 0.40, 0.81 and 0.
86 for observed OTUs, Shannon’s diversity and Pielou’s
evenness, respectively). Besides abolishing the nominal
association between disposition index and observed
OTUs, and revealing a nominally significant association
between observed OTUs and post-load 2-h glucose level,
adjusting for pre-pregnancy BMI had only a minor effect
on the relationship between glycaemic traits and alpha
diversity measures (Additional file 1: Figure S15).
Third trimester gut microbiota associated with weight
gain during pregnancy
Increased weight gain during pregnancy has been linked
to an increased risk of developing GDM [33]. In our
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cohort, women gained on average 8.7 ± 3.8 kg
(mean ± SD) leading up to the first visit during the third
trimester, with no difference between women with GDM
and women with normal glucose regulation (1.08 kg;
95%CI − 0.14–2.29) when adjusting for pre-pregnancy
BMI and gestational age. Disregarding diabetes status,
we identified 11 OTUs, mostly Clostridiales (7 of 11)
species, associated with gestational weight gain. Seven
OTUs were associated with lower weight gain, including
a Christensenella OTU (OTU_63) and an Alistipes OTU
(OTU_128). Four OTUs were associated with higher
weight gain, including an Eisenbergiella OTU (OTU_
258) and a Lactobacillus OTU (OTU_80) (Add-
itional file 2: Table S12). Nine higher order taxa, pre-
dominantly Firmicutes (8 of 9), where associated with
gestational weight gain at a nominal significance thresh-
old. Among these, the genera Coprococcus, Roseburia,
Butyricicoccus and Clostridium (sensu stricto) were posi-
tively correlated, and Fusibacter, Holdemania and an un-
classified Erysipelotrichaceae genus were inversely
correlated (Additional file 2: Table S13), yet none with-
stood correction for multiple testing.
Changes in diversity, community structure and
composition from pregnancy to postpartum
At an average of 8.8 months postpartum, 125 women
were re-examined of which 43 women with previous
GDM and 79 women with normal glucose regulation
pregnancies volunteered stool samples. Similar to the
third trimester, we did not see any difference in alpha di-
versity (observed OTUs, Shannon’s diversity and Pielou’s
evenness) between women with preceding GDM and
preceding normal pregnancy (Fig. 5). However, when
studying the changes from pregnancy to postpartum
using linear mixed regression modelling and accounting
for the repeated nature of measurements performed on
the same individual over time, we found a statistically
significant reduction in the number of observed OTUs
(P = 0.0002) and Shannon’s diversity (P = 0.012) irre-
spective of diabetes status (Fig. 5). Still, there was no
change in Pielou’s evenness index (P = 0.11). Similarly,
for beta diversity, we found a small significant change in
community structure as represented by weighted Uni-
Frac distances (R2 = 0.6%; P = 0.005) and unweighted
UniFrac distances (R2 = 0.5%; P = 0.001), irrespective of
diabetes status. Principal coordinate ordination showed
that the variation over time did not reflect a uniform
structural shift, but individual changes in community
structure (Fig. 1d), changes which were independent of
diabetes status.
Applying linear discriminant analyses, we identified
the genera Collinsella and Olsenella and all parent taxa
within phylum Actinobacteria as biomarkers of previous
GDM. Genus Clostridium sensu stricto and the parent
family Clostridiaceae_1, as well as the genera Hafnia,
Howardella and Dehalobacter, were also biomarkers of
previous GDM, whereas Fusobacterium and the parent
Fig. 5 Change in alpha diversity from the third trimester to postpartum. Alpha diversity in pregnancy and postpartum as represented
by observed richness (a), Shannon diversity (b) and Pielou evenness (c) based on the samples from GDM (n = 43) and normoglycaemic
(n = 79) women with available faecal samples from the third trimester and 8 months postpartum. Samples were rarefied to an equal
sequencing depth of 10,000 reads. Boxes represent interquartile range (IQR), with the inside line representing the median. Whiskers
represent values within 1.5 × IQR of the first and third quartiles. Circles represent individual samples with lines connecting the
samples from the same individual. Differences between GDM and normoglycaemic pregnancies within each time point were tested
using Student’s t test. Difference in richness, Shannon diversity and Pielou evenness between time points in GDM and normoglycaemic
women combined was tested using a mixed linear regression with a random effect of the subject in women with available samples at
both time points
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family Fusobacteriaceae and genus Ruminococcus2
(Ruminococcus of family Lachospiraceae) were markers
of a previous normoglycaemic pregnancy (Fig. 2c, d).
Postpartum, we identified 13 OTUs, which were differ-
entially abundant in women with preceding GDM and
women with a normal glucose regulation pregnancy.
Seven OTUs were enriched in women with previous
GDM, including two Faecalibacterium OTUs, one of
which (OTU_2674) was also enriched in women with
GDM during pregnancy. Six OTUs were depleted post-
partum in women with preceding GDM compared with
women with a previous normal glucose regulation preg-
nancy, including a Faecalibacterium (OTU_3232), a Bac-
teroides (OTU_4999), and an Isobaculum OTU (OTU_
595), which were also depleted in women with GDM
during pregnancy (Fig. 3b).
Using linear mixed regression model, we identified six
OTUs which exhibited a differential change from
antepartum to postpartum in women with preceding
GDM and normal pregnancy at a 10% FDR. Compared
with abundances during pregnancy, four OTUs assigned
to Bavariicoccus (OTU_431), Clostridium sensu stricto
(OTU_77), Bacteroides (OTU_138) and Veillonella
(OTU_1626), respectively, were enriched postpartum in
women with gestational diabetes but less abundant
postpartum in women with normal glucose regulation.
Contrastingly, two OTUs assigned to Ruminococcus
(OTU_152) (Lachnospiraceae) and Oscillibacter
(OTU_371) were depleted postpartum in women with
GDM but enriched in women with a preceding nor-
mal pregnancy (Fig. 6; Additional file 2: Table S14).
Seven higher order taxa, including the genera Rumi-
nococcus (Lachnospiraceae), Romboutsia, Clostridium
(sensu stricto), Alloprevotella, Veillonella, Hydrogenoa-
naerobacterium and Coprobacillus, exhibited differen-
tial change at a nominal significance threshold, but
Fig. 6 Operational taxonomic units exhibiting differential change from antepartum to postpartum in gestational diabetes and normoglycaemic
women. Based on the samples from GDM (n = 43) and normoglycaemic (n = 79) women with available faecal samples from the third trimester
and 8 months postpartum. Samples were rarefied to an equal sequencing depth of 10,000 reads. Boxes represent interquartile range (IQR), with
the inside line representing the median. Whiskers represent values within 1.5 × IQR of the first and third quartiles. Circles represent individual
samples. Change from the third trimester to 8 months postpartum between GDM and normoglycaemic women was modelled using mixed linear
regression ANOVA of the interaction between GDM status and time, and a post hoc t test was used to test the difference in change between
GDM and normoglycaemic women. Only the results significant at a false discovery rate of 10% are depicted. A full list of all nominally significant
results is available in Additional file 2: Table S5
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none withstood the correction for multiple testing
(Additional file 2: Table S15).
Discussion
Our study of women with GDM and normoglycaemic
pregnant women demonstrated that GDM diagnosed in
late pregnancy is associated with an aberrant gut micro-
bial composition at the time of diagnosis. About
8 months postpartum, the gut microbiota of previous
GDM women is still different from women who had a
normal pregnancy.
Interestingly, we found that OTU richness was higher
during late pregnancy compared with postpartum. Late
normal pregnancy is characterised by increased insulin
resistance and increased circulating levels of pro-
inflammatory cytokines [1]. A reduced richness of intes-
tinal microbiota has previously been associated with ele-
vated pro-inflammatory markers and insulin resistance
[34]. Our findings of higher alpha diversity in late preg-
nancy compared with postpartum could be influenced
by the difference in diet during pregnancy compared
with postpartum, as changes in nutrient composition
and caloric intake are known to affect gut microbiota in
humans [35, 36]. Expectedly, total energy intake was
lower in postpartum regardless of GDM status, but we
did not observe any major difference in the composition
of relative macronutrients intake between late pregnancy
and postpartum. During a short-term intervention based
on high-protein, energy-restricted diet, Cotillard and
colleagues observed an increase in gene richness, al-
though only in individuals with low gene count at base-
line [37]. Their findings suggested an antecorrelation
between energy intake and microbial richness, opposite
to the direction of effect observed in the present study,
when considering changes from late pregnancy to post-
partum. Similarly, results from a population-based Finish
study showed a positive correlation between OTU rich-
ness and HbA1c levels [38], also opposite to the direc-
tion of effect observed in the present study. Although an
effect of changes in diet and host metabolism cannot be
ruled out, these results suggest the involvement of other
factors in determining the change in microbial richness.
One such factor could be the host immune system,
which undergoes complex changes in the postpartum
period [39].
So far, comparisons of intestinal microbiota during
pregnancy and postpartum have not shown any differ-
ences in the abundance of taxa [8]. During a period of
3–16 months postpartum, it has been reported that 42
women with previous GDM had a relative lower abun-
dance of Firmicutes, but this study did not have samples
during pregnancy to compare with [40]. Firmicutes has
also been seen in low abundance in cohorts of type 2
diabetes patients [6, 41].
Our findings suggest that gut microbiota of women
with GDM have similarities with the microbiota re-
ported in patients with type 2 diabetes and associated
intermediary metabolic traits. For instance, the genus
Desulfovibrio is enriched in patients with type 2 diabetes
[6, 7]. Furthermore, the genus Collinsella has been asso-
ciated with increased fasting levels of insulin and
HOMA-IR in normoglycaemic pregnancies and is
enriched in non-pregnant patients with type 2 diabetes
[42, 43]. Collinsella has also been shown to decrease in
abundance concurrent with a diet-induced weight loss in
overweight individuals [44]. In infants, an increase in the
abundance of Collinsella from birth to 6 months of age
was associated with an increase in adiposity at 18 months
of age [45].
Collinsella was also enriched in abundance of the gut
microbiota postpartum in women with previous GDM,
making the taxon a potential candidate in the search for
bacteria that might contribute to later development of
type 2 diabetes. Similarly, species of Bacteriodes, Faecali-
bacterium and Isobaculum were depleted in both third
trimester and postpartum in women with GDM, and like
Collinsella, these species could contribute to the long-
term risk of type 2 diabetes in women with GDM.
At OTU level, reduced abundance of Faecalibacterium
has previously been reported in the third trimester of
healthy pregnant women [8]. In non-pregnant adults
with metabolic syndrome and type 2 diabetes, F. praus-
nitzii is reported to be depleted as well [42, 46]. In the
present study, we found Faecalibacterium OTUs both
enriched and depleted in pregnant women with GDM.
After adjustmen for pre-pregnancy BMI, we found an
enrichment of one species assigned to Faecalibacterium
in our GDM cohort. Furthermore, during pregnancy
species of Faecalibacterium presented divergent associa-
tions with hsCRP, suggesting that different strains of
Faecalibacterium are involved. An issue which can only
be addressed by applying shot-gun sequencing-based
metagenomics.
Blautia has been shown to be present with enriched
abundance in glucose-intolerant individuals [47] and to
be associated with metabolites reflecting an unhealthy
metabolic state in individuals with a high BMI [38].
These findings are much in line with our results showing
increased abundances associated with GDM, suggesting
that enriched Blautia abundance goes together with a
non-favourable metabolic profile. However, during preg-
nancy we found two species of Blautia associated with
lower levels of plasma hsCRP, pointing to the occurrence
of various subspecies of Blautia with opposite function-
ality related to host metabolism.
Similarly, Ruminococcus2 abundance suggests a simi-
larity between women with GDM and metabolic disor-
ders in non-pregnant adults, as Ruminococcus2 are
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enriched in type 2 diabetic patients [42], and Ruminococ-
cus gnavus has been reported to be enriched in people
with dysmetabolism and low microbial gene count [34].
Unexpectedly, we found that at the postpartum stage,
the relative abundance of Ruminococcus2 species de-
creased in the GDM group compared with the normo-
glycaemic group.
Investigating the relationships of metabolic traits and
microbial taxa across groups led us to a surprising dis-
covery of Akkermansia being associated with lower esti-
mates of whole-body insulin sensitivity. Akkermansia
has previously been reported to associate with improved
metabolic health and to be inversely correlated to fasting
plasma glucose and positively with insulin sensitivity
[48–50]. In rodents, probiotics supplementation with
Akkermansia improved glucose tolerance and insulin
sensitivity [51]. Our results suggest that Akkermansia
might have another impact on host physiology during
pregnancy than otherwise described or that we find an-
other subspecies of Akkermansia. The applied 16S rRNA
gene amplicon sequencing methods does, however, not
make it possible to investigate this finding at a deeper
taxonomic resolution.
Christensenella is known to be highly heritable and to
associate with low BMI [52]. Low abundance of Chris-
tensenella has been linked to a pre-diabetic health state
and has also been associated with increased levels of
acetate [38], a short chain fatty acid with an uncertain
involvement in host metabolism and appetite regulation
[53, 54]. In a rodent model, germ-free transplantation of
Christensenella indicated a protective effect against
weight gain [52]. We found that an OTU assigned to
Christensenella was associated with higher fasting
plasma glucose concentration, but the same Christense-
nella OTU was associated with lower weight gain during
pregnancy. At the postpartum stage, a species of Chris-
tensenella was associated with lower levels of plasma
hsCRP. All together, the findings suggest similarities be-
tween the features of Christensenella in pregnant and
non-pregnant adults, but also different direction of asso-
ciation between abundance of Christensenella and host
metabolic and inflammation phenotypes, indicating that
the Christensenella species found in our study by 16S
rRNA gene amplicon sequencing might not reflect the
entire spectrum of taxa in the Christensenellaceae
family.
When testing the association between different species
and glucose metabolism, only a few OTUs were associ-
ated with different glycaemic traits. However, the four
glycaemic traits used in our study represent different as-
pects of glucose metabolism [27], and physiologically
there is no imperative requirement of overlap in features
associated with different aspects of glucose metabolism.
The fact that we only see a moderate overlap in OTUs
associated with different glycaemic traits is not surpris-
ing, and might even be expected, given the different
physiological features they represent.
Gut microbial communities are known to be affected
by diet and weight in non-pregnant hosts [32, 37, 55].
The intestinal microbiota during pregnancy is associated
with pre-pregnancy BMI as well as weight gain [30, 31].
When adjusting for pre-pregnancy BMI, we similarly
demonstrated relationships between body composition
and gut microbiota also during pregnancy. Our results
confirm previous findings with enrichment of Bacter-
oides species in overweight pregnant women [31] and
Akkermansia enriched in normal weight pregnant
women [30, 31]. There was no overlap in taxonomic bio-
markers of GDM with markers of overweight or obesity
even though overweight is a risk factor for the develop-
ment of GDM [29]. In our study, species assigned to
Christensenella and Alistipes were associated with low
weight gain and Eisenbergiella and Lactobacillus were
associated with higher weight gain during pregnancy.
This finding is concurrent with the findings in non-
pregnant individuals as strains of Eisenbergiella and
Lactobacillus reuteri have previously been associated
with obesity [56, 57]. Of the taxa differentially abundant
in women with and without GDM, only two were signifi-
cantly correlated with pre-pregnancy BMI and only
weakly so, indicating that the observed compositional
differences were not strongly confounded by pre-
pregnancy BMI.
To our knowledge, this is the first study investigating
the gut microbiota composition at the time of GDM
diagnosis. A few studies with few participants have ex-
amined gut microbiota either weeks before or after
GDM diagnosis [8, 58]. Uniquely, for the present proto-
col, we could compare gut microbiota in the third tri-
mester with postpartum samples allowing identification
of taxa that exhibited differential abundance at the two
time points according to maternal metabolic status dur-
ing pregnancy. Another strength of the present protocol
is that the gut microbiota of study participants was not
confounded by antidiabetic drugs, a challenge recently
demonstrated in microbiota studies of patients with type
2 diabetes [59]. A limitation of our study was that we
did not have faecal samples before pregnancy. Also, our
suggestion of subspecies occurrence with divergent func-
tionalities calls for future shotgun-based sequencing
studies of the intestinal microbiome in GDM.
Conclusion
The intestinal microbiota composition of women with
GDM differs from the microbiota of comparable normo-
glycaemic pregnant women in the third trimester. Intri-
guingly, the disrupted GDM gut microbiota has
similarities with gut microbiota in individual patients
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with type 2 diabetes and associated intermediary meta-
bolic dysfunctions. Outside pregnancy, at an average of
8.8 months after delivery, we still saw an aberrant intes-
tinal microbiota of women with previous GDM. Pro-
spective studies are warranted to explore whether such
microbiota disruption conveys an increased risk of de-
veloping type 2 diabetes.
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